A Hollywood tragedy underscores the urgent need for stricter oversight in the rapidly growing at-home ketamine industry.
Story Highlights
- A doctor was sentenced for supplying ketamine to Matthew Perry.
- Perry’s death was attributed to the acute effects of ketamine.
- Legal proceedings involve multiple parties.
- Industry calls for stricter regulations to prevent future incidents.
Doctor Sentenced in Perry’s Ketamine Overdose Case
Salvador Plasencia, a doctor charged in connection with actor Matthew Perry’s overdose death, has been sentenced to 30 months in prison. The sentencing took place in a Los Angeles federal court this week.
Plasencia pleaded guilty to four counts of illegally distributing ketamine to Perry, a beloved star known for his role in the TV show “Friends.” This case highlights ongoing concerns about the misuse of ketamine in medical treatments.
Perry was found unresponsive in his Los Angeles home on October 28, 2023, with the medical examiner citing the “acute effects of ketamine” as the primary cause of death. Contributing factors included drowning, coronary artery disease, and buprenorphine effects, a medication for opioid use disorder. The incident has sparked calls for greater oversight of the availability and distribution of ketamine, especially for non-medical use.
Matthew Perry’s ‘Dr. Ketamine’ sentenced for his role in ‘Friends’ star’s OD death https://t.co/7pUO88sxDD pic.twitter.com/IHshmhLlWf
— New York Post (@nypost) December 3, 2025
Legal Implications and Industry Impact
Plasencia admitted to supplying Perry with 20 vials of ketamine, alongside lozenges and syringes, about a month before his death. Prosecutors revealed that Plasencia had enlisted another doctor, Mark Chavez, to continue supplying the drug, aiming to make Perry a regular client.
Chavez, who also pleaded guilty, is awaiting sentencing. These developments have prompted discussions on the ethical responsibilities of medical professionals in prescribing potentially dangerous substances.
Another figure in the case, Jasveen Sangha, known as the “Ketamine Queen,” is expected to be sentenced soon. Sangha has pleaded guilty to multiple counts related to ketamine distribution, including charges resulting in death or serious injury. These proceedings underline the need for stricter regulation in the at-home ketamine industry to prevent similar tragedies from occurring in the future.
Calls for Stricter Oversight
The tragic death of Matthew Perry and the subsequent legal actions against those involved have raised public awareness about the dangers of ketamine misuse.
Plasencia’s attorneys expressed hope that the case would serve as a warning to other medical professionals. They advocate for clearer protocols and oversight measures to ensure the safe use of ketamine, a drug that has legitimate medical applications but poses significant risks when misused.
With ongoing legal proceedings and the involvement of multiple parties, this case continues to capture public attention. As the at-home ketamine industry grows, the need for comprehensive oversight becomes increasingly apparent to prevent future tragedies and protect individuals from the potentially harmful effects of unsupervised drug use.
